Vitamin D in Pregnancy and Attention Deficit Hyperactivity Disorder-like Symptoms in Childhood
Vitamin D status during prenatal brain development may influence risk of attention deficit and hyperactivity disorder (ADHD) symptoms in childhood. However, there are no prospective studies addressing this hypothesis. We aimed to examine whether maternal vitamin D status in pregnancy is associated w...
Uloženo v:
| Vydáno v: | Epidemiology (Cambridge, Mass.) Ročník 26; číslo 4; s. 458 |
|---|---|
| Hlavní autoři: | , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
United States
01.07.2015
|
| Témata: | |
| ISSN: | 1531-5487, 1531-5487 |
| On-line přístup: | Zjistit podrobnosti o přístupu |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Vitamin D status during prenatal brain development may influence risk of attention deficit and hyperactivity disorder (ADHD) symptoms in childhood. However, there are no prospective studies addressing this hypothesis. We aimed to examine whether maternal vitamin D status in pregnancy is associated with risk of ADHD-like symptoms in offspring.
We conducted a prospective study analyzing data from 1,650 mother-child pairs from five birth cohorts embedded in the INMA Project (Spain, 1997-2008). Maternal vitamin D status in pregnancy was estimated by measuring plasma concentration of 25-hydroxyvitamin D3 [25(OH)D3] at 13 weeks of gestation. Children were assessed by teachers for ADHD-like symptoms at ages 4-5 years using the Diagnostic and Statistical Manual of Mental Disorders ADHD form list.
After adjustment, the number of total ADHD-like symptoms in children decreased by 11% per 10 ng/ml increment of maternal 25(OH)D3 concentration (incidence rate ratio [IRR] = 0.89; 95% confidence interval [CI] = 0.80, 0.98). Similarly, the number of symptoms in the ADHD subscales decreased in relation to higher maternal 25(OH)D3 concentration (IRR per 10 ng/ml increment = 0.89; 95% CI = 0.79, 0.99 for the inattention scale; and IRR = 0.88; 95% CI = 0.78, 0.99 for the hyperactivity-impulsivity scale). Using diagnostic criteria, we found an association of increasing maternal 25(OH)D3 with a lower risk of ADHD DSM-IV (relative risk ratio per 10 ng/ml increment = 0.87; 95% CI = 0.72, 1.06) and ICD-10 hyperkinetic disorder (relative risk ratio = 0.72; 95% CI = 0.49, 1.04) in children.
Higher maternal circulating levels of 25(OH)D3 in pregnancy are associated with lower risk of developing ADHD-like symptoms in childhood. |
|---|---|
| AbstractList | Vitamin D status during prenatal brain development may influence risk of attention deficit and hyperactivity disorder (ADHD) symptoms in childhood. However, there are no prospective studies addressing this hypothesis. We aimed to examine whether maternal vitamin D status in pregnancy is associated with risk of ADHD-like symptoms in offspring.
We conducted a prospective study analyzing data from 1,650 mother-child pairs from five birth cohorts embedded in the INMA Project (Spain, 1997-2008). Maternal vitamin D status in pregnancy was estimated by measuring plasma concentration of 25-hydroxyvitamin D3 [25(OH)D3] at 13 weeks of gestation. Children were assessed by teachers for ADHD-like symptoms at ages 4-5 years using the Diagnostic and Statistical Manual of Mental Disorders ADHD form list.
After adjustment, the number of total ADHD-like symptoms in children decreased by 11% per 10 ng/ml increment of maternal 25(OH)D3 concentration (incidence rate ratio [IRR] = 0.89; 95% confidence interval [CI] = 0.80, 0.98). Similarly, the number of symptoms in the ADHD subscales decreased in relation to higher maternal 25(OH)D3 concentration (IRR per 10 ng/ml increment = 0.89; 95% CI = 0.79, 0.99 for the inattention scale; and IRR = 0.88; 95% CI = 0.78, 0.99 for the hyperactivity-impulsivity scale). Using diagnostic criteria, we found an association of increasing maternal 25(OH)D3 with a lower risk of ADHD DSM-IV (relative risk ratio per 10 ng/ml increment = 0.87; 95% CI = 0.72, 1.06) and ICD-10 hyperkinetic disorder (relative risk ratio = 0.72; 95% CI = 0.49, 1.04) in children.
Higher maternal circulating levels of 25(OH)D3 in pregnancy are associated with lower risk of developing ADHD-like symptoms in childhood. Vitamin D status during prenatal brain development may influence risk of attention deficit and hyperactivity disorder (ADHD) symptoms in childhood. However, there are no prospective studies addressing this hypothesis. We aimed to examine whether maternal vitamin D status in pregnancy is associated with risk of ADHD-like symptoms in offspring.BACKGROUNDVitamin D status during prenatal brain development may influence risk of attention deficit and hyperactivity disorder (ADHD) symptoms in childhood. However, there are no prospective studies addressing this hypothesis. We aimed to examine whether maternal vitamin D status in pregnancy is associated with risk of ADHD-like symptoms in offspring.We conducted a prospective study analyzing data from 1,650 mother-child pairs from five birth cohorts embedded in the INMA Project (Spain, 1997-2008). Maternal vitamin D status in pregnancy was estimated by measuring plasma concentration of 25-hydroxyvitamin D3 [25(OH)D3] at 13 weeks of gestation. Children were assessed by teachers for ADHD-like symptoms at ages 4-5 years using the Diagnostic and Statistical Manual of Mental Disorders ADHD form list.METHODSWe conducted a prospective study analyzing data from 1,650 mother-child pairs from five birth cohorts embedded in the INMA Project (Spain, 1997-2008). Maternal vitamin D status in pregnancy was estimated by measuring plasma concentration of 25-hydroxyvitamin D3 [25(OH)D3] at 13 weeks of gestation. Children were assessed by teachers for ADHD-like symptoms at ages 4-5 years using the Diagnostic and Statistical Manual of Mental Disorders ADHD form list.After adjustment, the number of total ADHD-like symptoms in children decreased by 11% per 10 ng/ml increment of maternal 25(OH)D3 concentration (incidence rate ratio [IRR] = 0.89; 95% confidence interval [CI] = 0.80, 0.98). Similarly, the number of symptoms in the ADHD subscales decreased in relation to higher maternal 25(OH)D3 concentration (IRR per 10 ng/ml increment = 0.89; 95% CI = 0.79, 0.99 for the inattention scale; and IRR = 0.88; 95% CI = 0.78, 0.99 for the hyperactivity-impulsivity scale). Using diagnostic criteria, we found an association of increasing maternal 25(OH)D3 with a lower risk of ADHD DSM-IV (relative risk ratio per 10 ng/ml increment = 0.87; 95% CI = 0.72, 1.06) and ICD-10 hyperkinetic disorder (relative risk ratio = 0.72; 95% CI = 0.49, 1.04) in children.RESULTSAfter adjustment, the number of total ADHD-like symptoms in children decreased by 11% per 10 ng/ml increment of maternal 25(OH)D3 concentration (incidence rate ratio [IRR] = 0.89; 95% confidence interval [CI] = 0.80, 0.98). Similarly, the number of symptoms in the ADHD subscales decreased in relation to higher maternal 25(OH)D3 concentration (IRR per 10 ng/ml increment = 0.89; 95% CI = 0.79, 0.99 for the inattention scale; and IRR = 0.88; 95% CI = 0.78, 0.99 for the hyperactivity-impulsivity scale). Using diagnostic criteria, we found an association of increasing maternal 25(OH)D3 with a lower risk of ADHD DSM-IV (relative risk ratio per 10 ng/ml increment = 0.87; 95% CI = 0.72, 1.06) and ICD-10 hyperkinetic disorder (relative risk ratio = 0.72; 95% CI = 0.49, 1.04) in children.Higher maternal circulating levels of 25(OH)D3 in pregnancy are associated with lower risk of developing ADHD-like symptoms in childhood.CONCLUSIONHigher maternal circulating levels of 25(OH)D3 in pregnancy are associated with lower risk of developing ADHD-like symptoms in childhood. |
| Author | Rodriguez-Dehli, Cristina Tardón, Adonina Morales, Eva Vegas, Oscar Castilla, Ane Miren Sunyer, Jordi Andiarena, Ainara Rodríguez-Bernal, Clara L Ballester, Ferran Julvez, Jordi Torrent, Maties |
| Author_xml | – sequence: 1 givenname: Eva surname: Morales fullname: Morales, Eva organization: From the aCentre for Research in Environmental Epidemiology (CREAL), Barcelona, Catalonia, Spain; bVirgen de la Arrixaca Universtiy Hospital, IMIB-Arrixaca Research Institute, Murcia, Spain; cCIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; dHospital del Mar Medical Research Institute (IMIM), Barcelona, Catalonia, Spain; eUniversitat Pompeu Fabra (UPF), Barcelona, Catalonia, Spain; fIB-SALUT, Area de Salut de Menorca, Balearic Islands, Spain; gUniversity of Valencia, Valencia, Spain; hCenter for Public Health Research (CSISP-FISABIO), Valencia, Spain; iDepartment of Basic Psychological Processes and Their Development, Basque Country University UPV/EHU, San Sebastian, Spain; jBiodonostia Institute, San Sebastian, Gipuzkoa, Spain; kPublic Health Laboratory, Basque Government, Bilbao, Spain; lHospital San Agustín, Avilés, Asturias, Spain; and mUniversity of Oviedo, Asturias, Spain – sequence: 2 givenname: Jordi surname: Julvez fullname: Julvez, Jordi – sequence: 3 givenname: Maties surname: Torrent fullname: Torrent, Maties – sequence: 4 givenname: Ferran surname: Ballester fullname: Ballester, Ferran – sequence: 5 givenname: Clara L surname: Rodríguez-Bernal fullname: Rodríguez-Bernal, Clara L – sequence: 6 givenname: Ainara surname: Andiarena fullname: Andiarena, Ainara – sequence: 7 givenname: Oscar surname: Vegas fullname: Vegas, Oscar – sequence: 8 givenname: Ane Miren surname: Castilla fullname: Castilla, Ane Miren – sequence: 9 givenname: Cristina surname: Rodriguez-Dehli fullname: Rodriguez-Dehli, Cristina – sequence: 10 givenname: Adonina surname: Tardón fullname: Tardón, Adonina – sequence: 11 givenname: Jordi surname: Sunyer fullname: Sunyer, Jordi |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25867115$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNUEtLw0AYXKRiH_oPRHL0krqPbDY5lrZaoaDg42jY7H6xq8luzG6F_HsjVugcZgZmmMNM0cg6CwhdEjwnOBc369V6jo9Bc3qCJoQzEvMkE6MjP0ZT7z8wJoIRfobGlGepIIRP0NurCbIxNlpFAz128G6lVX0krY4WIYANxg0hVEaZEG36Fjqpgvk2oY9WxrtOQxfX5hOip75pg2v8785yZ2q9c06fo9NK1h4uDjpDL7fr5-Um3j7c3S8X21glOaYxSIkrykuBU5llucpZkmLNU62SkmrKuSYpw0xBNlhWVaAFlCypKGaQ0EzQGbr-220797UHH4rGeAV1LS24vS9ImqVY4ISxoXp1qO7LBnTRdqaRXV_8f0J_AEGyZe0 |
| CitedBy_id | crossref_primary_10_1016_j_pharep_2018_02_005 crossref_primary_10_1016_j_heliyon_2023_e19367 crossref_primary_10_1038_mp_2016_213 crossref_primary_10_1016_j_neuro_2016_03_014 crossref_primary_10_1016_j_endinu_2016_11_002 crossref_primary_10_2174_1381612826666200506093858 crossref_primary_10_1096_fj_201902924RR crossref_primary_10_1111_ppe_12736 crossref_primary_10_1089_cap_2019_0059 crossref_primary_10_3389_fpsyg_2021_707500 crossref_primary_10_1097_TIN_0000000000000202 crossref_primary_10_1177_0004867416670013 crossref_primary_10_1016_j_eujim_2018_10_006 crossref_primary_10_1080_1028415X_2016_1262097 crossref_primary_10_3389_fimmu_2019_02739 crossref_primary_10_1001_jamanetworkopen_2023_14319 crossref_primary_10_1177_1721727X231161013 crossref_primary_10_1016_j_jaac_2019_11_021 crossref_primary_10_1039_c6pp90004f crossref_primary_10_1016_j_clnesp_2017_11_011 crossref_primary_10_3389_fnut_2024_1465875 crossref_primary_10_1080_14767058_2017_1408065 crossref_primary_10_1017_S0033291724002472 crossref_primary_10_1186_s13063_022_06837_1 crossref_primary_10_1038_s41380_019_0357_9 crossref_primary_10_1016_j_endien_2016_11_003 crossref_primary_10_1016_j_jad_2020_01_005 crossref_primary_10_1093_advances_nmx002 crossref_primary_10_1093_ije_dyab194 crossref_primary_10_1016_j_jaac_2021_04_009 crossref_primary_10_1007_s12402_018_0276_7 crossref_primary_10_3389_fped_2025_1492429 crossref_primary_10_1093_nutrit_nuy071 crossref_primary_10_1007_s00787_021_01894_4 crossref_primary_10_1159_000508052 crossref_primary_10_1007_s00787_017_0949_3 crossref_primary_10_1016_j_jsbmb_2018_01_015 crossref_primary_10_3389_fnins_2019_01335 crossref_primary_10_1016_j_mehy_2018_08_022 crossref_primary_10_1016_S2215_0366_25_00099_9 crossref_primary_10_1038_s41598_022_23432_1 crossref_primary_10_1038_s41598_019_51325_3 crossref_primary_10_1016_j_neuroimage_2020_116514 crossref_primary_10_3389_fpsyt_2021_566368 crossref_primary_10_3390_ijms24010063 crossref_primary_10_1098_rsob_200063 crossref_primary_10_1007_s15016_016_5751_9 crossref_primary_10_1177_00048674241272018 crossref_primary_10_1530_JOE_18_0541 crossref_primary_10_1016_j_ajcnut_2023_12_002 crossref_primary_10_1093_ije_dyz197 crossref_primary_10_3390_children12030392 crossref_primary_10_1007_s12519_018_0209_8 crossref_primary_10_1007_s00787_017_1023_x crossref_primary_10_1139_cjpp_2018_0381 crossref_primary_10_3390_ijerph17217704 crossref_primary_10_1016_j_ijheh_2017_02_008 crossref_primary_10_1080_15592294_2024_2413815 crossref_primary_10_1016_j_psychres_2022_114977 crossref_primary_10_1007_s40473_024_00278_7 crossref_primary_10_3389_fneur_2020_567407 crossref_primary_10_1097_GCO_0000000000000641 crossref_primary_10_3390_nu13041126 crossref_primary_10_1080_19381980_2015_1137400 crossref_primary_10_1016_j_jad_2020_12_033 crossref_primary_10_2147_NDT_S407731 crossref_primary_10_1111_jcpp_12570 crossref_primary_10_3390_nu14204353 crossref_primary_10_1210_clinem_dgae395 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1097/EDE.0000000000000292 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Public Health |
| EISSN | 1531-5487 |
| ExternalDocumentID | 25867115 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | Spain |
| GeographicLocations_xml | – name: Spain |
| GroupedDBID | --- .-D .55 .Z2 01R 0R~ 1J1 40H 4Q1 4Q2 4Q3 53G 5GY 5VS 71W 77Y 7O~ 8L- AAAAV AAAXR AACGO AAGIX AAHPQ AAIKC AAIQE AAMNW AAMOA AAMTA AANCE AAQKA AARTV AASCR AASOK AAXQO AAYEP ABASU ABBHK ABBUW ABDIG ABJNI ABPLY ABTLG ABVCZ ABXSQ ABXVJ ABZAD ABZZY ACCJW ACDDN ACEWG ACGFO ACGFS ACHIC ACHQT ACIJW ACILI ACLDA ACWDW ACWRI ACXJB ACXNZ ACZKN ADFPA ADGGA ADHPY ADNKB ADQXQ ADULT AE3 AE6 AEETU AENEX AEUPB AEXZC AFBFQ AFDTB AFFNX AFUWQ AGINI AHOMT AHQNM AHVBC AIJEX AINUH AJCLO AJIOK AJNWD AJNYG AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI ANHSF AOHHW AOQMC AQVQM BOYCO BQLVK BS7 BYPQX C45 CGR CS3 CUY CVF DCCCD DIWNM DU5 DUNZO E.X EBS ECM EEVPB EIF EJD ERAAH EX3 F2M F2N F5P FCALG FL- FW0 GNXGY GQDEL H0~ HGD HLJTE HQ3 HTVGU HZ~ IKREB IKYAY IN~ IPNFZ IPSME JAAYA JBMMH JENOY JF9 JG8 JHFFW JK3 JK8 JKQEH JLS JLXEF JPM JSG JST K8S KD2 L-C N9A NPM N~7 N~B N~M O9- OAG OAH OCUKA ODA OLG OLH OLU OLY OPUJH ORVUJ OUVQU OVD OVDNE OVIDH OVLEI OWU OWV OWW OWX OWY OWZ OXXIT P-K P2P R58 RIG RLZ S4R S4S SA0 T8P TEORI TSPGW V2I VVN W3M WOQ WOW X3V X3W X7M XXN XYM YCJ YOC ZFV ZGI ZZMQN 7X8 AAFWJ ABPXF ADKSD ADSXY |
| ID | FETCH-LOGICAL-c4902-eaa0f25b706a889c93460d56dc4b2d255d16303ce855d3ffed7eb34f203e42872 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 77 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000357189400003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1531-5487 |
| IngestDate | Thu Oct 02 04:19:58 EDT 2025 Thu Apr 03 07:06:23 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4902-eaa0f25b706a889c93460d56dc4b2d255d16303ce855d3ffed7eb34f203e42872 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | http://hdl.handle.net/10651/34451 |
| PMID | 25867115 |
| PQID | 1686070433 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_1686070433 pubmed_primary_25867115 |
| PublicationCentury | 2000 |
| PublicationDate | 2015-July |
| PublicationDateYYYYMMDD | 2015-07-01 |
| PublicationDate_xml | – month: 07 year: 2015 text: 2015-July |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Epidemiology (Cambridge, Mass.) |
| PublicationTitleAlternate | Epidemiology |
| PublicationYear | 2015 |
| SSID | ssj0017315 |
| Score | 2.4554205 |
| Snippet | Vitamin D status during prenatal brain development may influence risk of attention deficit and hyperactivity disorder (ADHD) symptoms in childhood. However,... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 458 |
| SubjectTerms | Attention Deficit Disorder with Hyperactivity - epidemiology Calcifediol - blood Child, Preschool Cohort Studies Female Humans Incidence Linear Models Male Pregnancy Pregnancy Complications - blood Pregnancy Complications - epidemiology Pregnancy Trimester, First Prenatal Exposure Delayed Effects - epidemiology Prospective Studies Spain - epidemiology Vitamin D Deficiency - blood Vitamin D Deficiency - epidemiology |
| Title | Vitamin D in Pregnancy and Attention Deficit Hyperactivity Disorder-like Symptoms in Childhood |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/25867115 https://www.proquest.com/docview/1686070433 |
| Volume | 26 |
| WOSCitedRecordID | wos000357189400003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1JS8NAFB7UehDEfakbI3gNTTNLMicptqUXS8GFngyTzESCNqlNFPrvfZNJ7EkQzGEuISFM3rz9fR9CN13N4IYJcohgDhWBAj2oXScQnEkO9stLkopswh-Pg-lUTOqEW1G3VTY6sVLUKo9NjrzT5QEH8aSE3M4_HMMaZaqrNYXGOmoRcGWMVPvTVRXBtwwGcKi7jvHMm9E54XcG_YGFLmwuryqG_uJkVsZmuPvfz9xDO7WbiXtWLvbRms4O0LbN0WE7enSIXp7TUs7SDPcxLJOFfjXoG0ssM4V7ZWkbIXFfG5CJEo8gYq1GqgzbBG5QO5339E3jh-VsXuazwrznByz5CD0NB493I6fmW3BiKkAxaindxGOR73IZBCIWhHJXMa5iGnkKYg8FzptLDNEpUyRJtPIhFKeJ5xJtIi_vGG1keaZPEaaxYmD2KI8loS6JBPe1BsNnqqQRRD1tdN1sXwjybIoUMtP5ZxGuNrCNTuw_COcWeCP0mEHj67KzPzx9jrbAt2G2s_YCtRI4zfoSbcZfZVosripBgXU8uf8GZB_Fcw |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Vitamin+D+in+Pregnancy+and+Attention+Deficit+Hyperactivity+Disorder-like+Symptoms+in+Childhood&rft.jtitle=Epidemiology+%28Cambridge%2C+Mass.%29&rft.au=Morales%2C+Eva&rft.au=Julvez%2C+Jordi&rft.au=Torrent%2C+Maties&rft.au=Ballester%2C+Ferran&rft.date=2015-07-01&rft.eissn=1531-5487&rft.volume=26&rft.issue=4&rft.spage=458&rft_id=info:doi/10.1097%2FEDE.0000000000000292&rft_id=info%3Apmid%2F25867115&rft_id=info%3Apmid%2F25867115&rft.externalDocID=25867115 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1531-5487&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1531-5487&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1531-5487&client=summon |